[HTML][HTML] A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in …

CE Edvardsson, J Vestlund, E Jerlhag - European Journal of Pharmacology, 2021 - Elsevier
The orexigenic peptide ghrelin increases the release of dopamine in the nucleus
accumbens (NAc) shell via central ghrelin receptors, especially those located in the ventral …

A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus …

CE Edvardsson, J Vestlund, E Jerlhag - European Journal of …, 2021 - europepmc.org
The orexigenic peptide ghrelin increases the release of dopamine in the nucleus
accumbens (NAc) shell via central ghrelin receptors, especially those located in the ventral …

A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus …

CE Edvardsson, J Vestlund… - European journal of …, 2021 - pubmed.ncbi.nlm.nih.gov
The orexigenic peptide ghrelin increases the release of dopamine in the nucleus
accumbens (NAc) shell via central ghrelin receptors, especially those located in the ventral …

[PDF][PDF] A ghrelin receptor antagonist reduces the ability of ghrelin, alcohol or amphetamine to induce a dopamine release in the ventral tegmental area and in nucleus …

CE Edvardsson, J Vestlund… - European Journal of …, 2021 - researchgate.net
The orexigenic peptide ghrelin increases the release of dopamine in the nucleus
accumbens (NAc) shell via central ghrelin receptors, especially those located in the ventral …